Q-omics provides the consensus-scored RPS10P14 profile across patient tissues and cancer cell-line models. RPS10P14 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, RPS10P14 is differentially expressed in 5, with the highest sampling consensus in THCA. Additionally, RPS10P14 RNA expression shows 18,005 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight UCEC, THCA, and LSCC as cancer lineages where RPS10P14 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS10P14 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS10P14 survival associations across molecular data types. RPS10P14 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS10P14 RNA expression–survival associations across cancer types. High RPS10P14 expression shows unfavorable associations in UCEC, OV and LUAD, but favorable associations in KIRC, LUSC and BRCA. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify UCEC as the clearest survival context for RPS10P14 RNA expression.
This table summarizes RPS10P14 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPS10P14. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS10P14 shows lower tumor expression in THCA and higher tumor expression in KIRC, PRAD, LUAD and HNSC. The THCA box plot shows higher RPS10P14 RNA expression in normal versus tumor tissue (log2 FC = −0.150, t-test p < 0.001).
This table shows molecular features associated with RPS10P14 in patient tissues and cancer cell lines. In patient samples, RPS10P14 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
